- Home
- AKRO vs SON Comparison
AKRO vs SON Comparison
Compare AKRO & SON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKRO | SON |
|---|---|---|
| Founded | 2017 | 1899 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.0B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | AKRO | SON |
|---|---|---|
| Price | $54.65 | $43.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $73.56 | $56.83 |
| AVG Volume (30 Days) | ★ 2.4M | 932.8K |
| Earning Date | 11-07-2025 | 10-22-2025 |
| Dividend Yield | N/A | ★ 4.89% |
| EPS Growth | N/A | ★ 116.52 |
| EPS | N/A | ★ 6.30 |
| Revenue | N/A | ★ $7,114,053,000.00 |
| Revenue This Year | N/A | $45.04 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.88 |
| Revenue Growth | N/A | ★ 67.86 |
| 52 Week Low | $21.34 | $38.65 |
| 52 Week High | $58.40 | $51.48 |
Technical Indicators
Market Signals| Indicator | AKRO | SON |
|---|---|---|
| Relative Strength Index (RSI) | 68.63 | 66.20 |
| Support Level | $54.30 | $42.52 |
| Resistance Level | $54.70 | $43.84 |
| Average True Range (ATR) | 0.17 | 0.82 |
| MACD | -0.10 | 0.22 |
| Stochastic Oscillator | 71.07 | 91.32 |
Price Performance
Historical ComparisonAbout AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About SON Sonoco Products Company
Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.